# Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF

> **NCT06468527** · PHASE2 · COMPLETED · sponsor: **Kors van der Ent** · enrollment: 41 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Diponecaftor
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06468527
- **Lead sponsor:** Kors van der Ent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-03
- **Primary completion:** 2025-06-26
- **Final completion:** 2025-06-26
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06468527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06468527, "Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06468527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*